palbonix-125mg& 100mg(Palbociclib)
Description
Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
- an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
- fulvestrant in women with disease progression following endocrine therapy.
Product Features:
| Product Name | : | Palbonix |
| Generic Name | : | Palbociclib |
| Formulation | : | Capsule |
| Available Pack Size | : | 21’s Pot |
| Available Strength | : | 125mg |
| Registrations | : | Export Only |
Be the first to review “palbonix-125mg& 100mg(Palbociclib)”
Reviews
There are no reviews yet.